NCT04141982View on ClinicalTrials.gov

Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)

CompletedOBSERVATIONAL
Enrollment

680

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

March 18, 2020

Study Completion Date

March 18, 2020

Conditions
Tuberculosis
Interventions
DIAGNOSTIC_TEST

T-Cell SelectTM Kit

The T-Cell Select kit is intended for the isolation of mononuclear immune cells from whole blood, using positive selection via a magnetic bead-based cell separation system, for use in the T-SPOT.TB assay.

Trial Locations (4)

43210

Ohio State University, Columbus

78520

University of Texas Health Science Center at Houston, School of Public Health in Brownsville, Brownsville

02721

NECCR Primacare Research, LLC, Fall River

Unknown

Rapitrade, Cape Town

Sponsors

Lead Sponsor

Oxford Immunotec
All Listed Sponsors
lead

Oxford Immunotec

INDUSTRY